INTRODUCTION
Endovascular therapy (ET) is a promising intervention for acute ischemic stroke (AIS). After three recent studies failed to demonstrate any benefit for these procedures over medical therapy, however, there has been increased scrutiny on methods of identifying patients likely to benefit from ET. [1] [2] [3] Two features that have been focused upon and shown to play a role in influencing ultimate clinical outcome include time from symptom onset to recanalization as well as initial stroke severity at presentation in the form of the NIH stroke scale (NIHSS) or infarct volume on imaging. 4 5 What then determines the initial stroke severity? It is not uncommon to encounter patients of comparable age, intracranial occlusion, and time from symptom onset with dramatically different cerebral injuries upon arrival to the hospital. One physiologic feature that likely plays a role in the varied presentations of these patients is the status of collaterals at the time of the vessel occlusion. The presence of adequate collateral flow has been shown to have a powerful effect on patient outcomes, and has been associated with decreased ischemia on CT and MRI, reduced hemorrhagic conversion, improved recanalization rates, and improved clinical outcomes. [6] [7] [8] [9] [10] [11] [12] [13] Methods of collateral assessments in these studies included conventional angiography, MRI, and CT angiography (CTA) evaluated as source, maximal intensity projection, and multiplanar reconstructed images. 6 12 14 15 While the association of robust collaterals and improved outcomes in AIS has been made clear, a direct relationship between the two has not been established. These prior studies have demonstrated that collateral flow is also associated with reduced initial infarct volume and NIHSS, markers that have been independently shown to lead to good clinical outcome. Thus it is possible that improved collaterals could merely serve as a marker of reduced initial injury, and have no causative role in determining outcome. To address this issue, we sought to provide a single comprehensive view on the influence of collaterals on multiple outcome measures after AIS in an endovascular treatment cohort using the gold standard methodology for their assessment, cerebral angiography, and a single grading metric. We hypothesize that collateral grade in fact determines the degree of initial injury at the time of presentation and, as such, plays a pivotal role in determining the outcome. In thinking of the physiology of ischemic injury to the brain, the extent of infarction as well as the severity of clinical deficit is a function of the degree of reduction in cerebral blood flow, the areas of the brain involved, and the duration of ischemia. 16 By matching patients with large vessel AIS by age, vessel occlusion, and time, we paired individuals with comparable ischemic burdens and determined whether changes in collateral grade alone led to significant differences in initial stroke severity as well as ultimate clinical outcome. We tested whether changes in collateral grade could independently lead to changes in the degree of initial injury, and thus directly modulate outcome.
METHODS
Demographic, clinical, laboratory, and radiographic data were prospectively collected on a consecutive cohort of patients who received ET (intra-arterial thrombolytic therapy or mechanical thrombectomy) for acute cerebral ischemia at a single tertiary referral center between September 2004 and January 2012.
Patients were included in this study if they presented with symptoms of acute cerebral ischemia within the anterior circulation and underwent conventional angiography for consideration of ET. The decision to proceed with ET at our institution is based on patient demographics, clinical history and examination, as well as imaging demonstration of large vessel occlusion that would be amenable to ET. Patients with occlusions that were felt by the interventionalist to be inaccessible or would confer significant risk were not included in this cohort. Patients with large infarct volumes on initial imaging are generally not offered ET. Conversely, patients with substantive clinical improvement after intravenous tissue plasminogen activator (tPA) are observed closely but not treated with ET without recurrence of symptoms or worsening that is shown on imaging to be due to continued ischemia. All patients with visualized large vessel occlusions without large infarcts on imaging are evaluated for possible ET, regardless of eligibility for intravenous tPA. Patients evaluated during this time period may have been enrolled in clinical trials of ET or non-ET interventions. As a result of these selection criteria, the resultant dataset reflects routine clinical practice while capturing advanced imaging data.
All patients underwent comprehensive diagnostic cerebral angiography, including injection of both internal carotid arteries and the dominant vertebral artery, with image acquisition into the late venous phase to assess collateral circulation from all possible sources. All cases had injections demonstrating the ipsilateral anterior cerebral artery and posterior cerebral artery. Angiographic collateral grade was evaluated with the American Society of Interventional and Therapeutic Neuroradiology/ Society of Interventional Radiology (ASITN/SIR) Collateral Flow Grading System on baseline angiography. 17 This angiographic scale assigns patients to grade 0 (no collaterals visible to the ischemic site), 1 (slow collaterals to the periphery of the ischemic site with persistence of some of the defect), 2 (rapid collaterals to the periphery of ischemic site with persistence of some of the defect and to only a portion of the ischemic territory), 3 (collaterals with slow but complete angiographic blood flow of the ischemic bed by the late venous phase), and 4 (complete and rapid collateral blood flow to the vascular bed in the entire ischemic territory by retrograde perfusion). Collateral rating was performed by one author (DSL) with extensive experience in angiographic interpretation in acute stroke, in a retrospective manner, blinded to the clinical presentation and outcomes. Dichotomization was then performed by dividing into groups of 0-2 vs 3-4. Assessment of vascular recanalization was based on the Thrombolysis in Cerebral Infarction (TICI) scale. 17 Hemorrhagic transformation was categorized as hemorrhagic infarctions or parenchymal hematomas as previously described. 18 Routine clinical care included MRI before angiography therapy if not contraindicated. Follow-up imaging was then performed 24 h after arrival and prior to discharge. Diffusion-weighted imaging (DWI) and perfusion-weighted imaging (PWI) lesion volume measurements were performed by one of the authors blinded to the clinical information using a computer-assisted volumetric analysis program (Olea Medical, La Ciotat, France). Diffusion was measured at three values of b (b=0, 500, 1000 s/mm 2 ), and average ADC maps were generated. DWI volumes were quantified from analysis of isotropic b1000 images and ADC maps with threshold of ADC <600. Final infarct measurements were gathered from the final MRI performed prior to discharge. PWI volumes were determined with Tmax of ≥2, 6, 8, and 10 s. 19 Univariate comparisons between categorical variables were made using the Fisher exact test and the χ 2 test, and between continuous variables using the Mann-Whitney U test. Matching algorithms were written in Matlab (R2010a, The Mathworks, Natick, Massachusetts, USA) to pair patients based on age, vessel occlusion, and time of onset by finding the control patient (collateral grade 0-2) that most closely matched each case patient (collateral grade 3-4). Comparisons between ageand time-matched cohorts were made using the Wilcoxon matched pairs test. Spearman correlation coefficient was used to analyze the association of collateral grade with the TICI recanalization. Multivariate analyses were performed using binomial logistic regression. All statistical analyses were performed using commercially available software (Prism 5.0a, GraphPad Software, La Jolla, California, USA and Matlab R2010a, The Mathworks). p<0.05 was considered statistically significant.
RESULTS
A total of 117 patients treated with ET for AIS were enrolled. This cohort is comparable in size to or larger than other recent studies on collaterals in ET. [20] [21] [22] Baseline characteristics for the cohort are shown in table 1. Significantly fewer patients of white ethnicity were found to have grade 3-4 collaterals at the time of angiography. Patients with higher collateral grades presented with lower NIHSS. There were no significant differences in age, gender, past medical history, baseline function, vessel occlusion, or timing of arrival at the hospital, evaluation, and treatment.
Treatment characteristics and outcomes are shown in table 2. Patients with more robust collaterals had smaller DWI lesions on arrival, with no significant difference in PWI volumes. Treatments modalities included intravenous tPA, intra-arterial tPA, and mechanical thrombectomy. The majority of patients had complete vessel occlusions (TICI 0) on arrival, and 41% and 53% achieved TICI 2b or 3 flow after the procedure in the groups with the lower 0-2 grade and higher 3-4 grade collateral groups, respectively. Improved collateral grade correlated positively with TICI reperfusion (r=0.
We then sought to address whether collateral status predicted severity of stroke independent of age and last known well time. We selected a subset of patients from our cohort with proximal vessel occlusions (internal carotid artery (ICA) or proximal middle cerebral artery (M1)) and matched them pairwise for these two variables. As shown in table 3, in the setting of comparable vessel occlusions, age-and time-matched patients with higher collateral grade presented with lower NIHSS, had smaller stroke volumes on initial and final DWI, better mRS at time of discharge, and shorter length of stay in hospital. We then explored the relationship of collateral status with initial stroke severity in a multivariate analysis, as shown in table 4. Of note, we chose NIHSS 17 as our dichotomization point in our binomial logistic regression as this was the median value of our cohort. Collateral grade 0-2 and age >80 were significantly associated with worse initial stroke severity. There was a trend a towards higher likelihood of NIHSS ≥18 with ICA occlusions versus all others.
DISCUSSION
In this cohort of patients with AIS treated with ET, higher collateral grade as assessed by the ASITN/SIR grading scheme on angiography at the time of presentation was associated with improved reperfusion rates after endovascular intervention, decreased post-procedural hemorrhage, smaller infarcts on presentation and discharge, as well as improved neurological function on arrival to the hospital, discharge, and 90 days later. Hospital stays were also significantly briefer. In order to address the issue of the direct influence of collateralization on initial stroke severity and outcome, we matched patients based on vessel occlusion, time from last known well to presentation, and age. These factors are those used most consistently in models of predicting clinical outcome in AIS. 5 23-26 It is worth noting that, while these models also include measures of initial stroke severity (NIHSS or initial DWI volume), we did not include these features in the matching algorithm as, in this paradigm, we used these factors as outcome measures, as measures of the extent of the patient's injury on arrival. We found that, among these matched patients, superior collaterals were associated with smaller strokes at presentation and improved outcomes. This finding was corroborated in our multivariate analysis as well. Thus, for a given arterial occlusion over time, improved collaterals at the time of imaging led to smaller infarcts. In a multivariate analysis, lower collateral grade increased the likelihood of increased stroke severity independent of age, time of onset, and vessel occlusion. By driving a reduction in initial stroke severity at presentation, improved collateral flow has a direct role in the final clinical outcome.
Adequacy of reperfusion is another key factor in determining outcome after ET. Our findings continue to support the need for complete recanalization as we found that, even in the setting of robust collateral flow, higher grade TICI reperfusion is associated with improved rates of good outcome. On the other hand, we also found that patients with poor collaterals could have a good outcome in the setting of adequate reperfusion. Besides adequacy of reperfusion, the other variable that can be addressed by the physician rendering treatment is time. Time to reperfusion has emerged as a key variable in both intravenous lytic therapy and ET, but it is worth noting that not all patients who are treated rapidly do well. 5 26 Conversely, not all patients who are treated at later time points do poorly. Perhaps the key variable that determines an individual's vulnerability to time is the quality of collateral flow to the territories at risk. We found that patients matched by age, vessel occlusion, and time of symptom onset had improved outcomes with improved collateral grades in spite of longer times from last known well to groin puncture. Strict cutoffs for ET based on time alone are unlikely to capture the varied physiology that is a function of each individual's collateral status.
The relationship between PWI volume, PWI/DWI mismatch, and collateral grade is not clear. In our study we did not note an association in total volume of PWI abnormality and collateral status consistent with other studies, and the elevations in PWI/ DWI mismatch ratios in our patients with robust collaterals is probably due to their significantly reduced DWI volumes. 10 On the other hand, in a smaller cohort also using MRI perfusion and angiographic collateral grading, a linear relationship between collateral grade and PWI volume was seen, with lower collateral scores associated with larger PWI volumes. 22 Other smaller cohorts have shown non-statistically significant trends towards a relationship between the two. 27 In our data there was a trend towards larger PWI volumes defined by Tmax ≥8 and collateral status, and so it is possible that larger cohorts will be able to define this relationship more accurately.
Limitations to this study include its retrospective nature and, because of the reliance on angiography, a selection bias in only choosing patients considered for ET. Patients without large vessel occlusions, with significant brain injury on imaging, or with delayed presentations from symptom onset would likely have been excluded. Further, our finding that higher collateral grades were associated with improved TICI reperfusion scores may have been confounded by more aggressive recanalization attempts in the setting of well-visualized collateral flow. In addition, angiography is an invasive technique that may not be indicated in many presentations of AIS. In fact, an assessment of collateral flow prior to angiography may be helpful in determining whether angiography and ET are indicated. Non-invasive measurements of collateral flow using CTA have been shown to correlate with outcome in AIS and also to correlate with initial DWI lesion. 7 28 However, because CTA provides a structural assessment and does not measure blood flow, collateral grades can often be elevated when compared with angiography. In addition, as the field of ET for AIS advances, time from symptom onset to reperfusion is emerging as a key target. One study has noted a 12% lower probability of good outcome for every 30 minute delay in reperfusion. 5 As a result, there may be less justification for obtaining contralateral injections prior to the initiation of the recanalization portion of the procedure.
To date, reperfusion interventions comprise the only acute treatment modalities for patients presenting with ischemic stroke. In spite of almost 20 years of experience, use of intravenous tPA remains low nationwide, with estimates of 1-5% of stroke patients receiving this therapy. 29 30 Substantial effort has been placed into identifying additional patients who may benefit from thrombolytic or mechanical revascularization techniques. In this paper we show that patients with adequate collateral flow can present with decreased stroke severity and, in this population, adequate reperfusion with ET increases the likelihood of a good outcome. Assessments of collateral status at the time of presentation may expand the population of patients in whom reperfusion is safe, effective, and ultimately leads to an improvement in functional outcomes.
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